- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04660851
Improving Diet Protein Intake in Middle-aged Women
December 7, 2020 updated by: Sareen Gropper, PhD, RDN, LDN, Florida Atlantic University
The study sought to examine the effectiveness of nutrition education with and without diet coaching on dietary protein intake and muscle mass, strength and function among a group of middle-aged women.
Study Overview
Detailed Description
The study sought to examine the effectiveness of nutrition education alone and with 10 weeks of diet coaching on dietary protein intake and muscle mass, strength and function among a group of middle-aged women.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Boca Raton, Florida, United States, 33431
- Florida Atlantic University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- able to understand and respond to questions or instructions in English
- working telephone
- willingness to consume protein-containing animal products,
- willingness to make changes to the diet
Exclusion Criteria:
- self-reported information that they have been told by a medical doctor that they have kidney (renal) disease
- current or past history of a diagnosed eating disorder
- have an internal cardiac pacemaker/defibrillator or other metal-type implant present
- vegan dietary practices
- refusal to make changes to usual dietary protein intake
- usual dietary protein intake greater than 1.2 g per kg body weight
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Coached
10 weeks of diet coaching
|
10-weeks of diet coaching weekly by telephone to improve dietary protein intake
|
|
No Intervention: Not-coached
No coaching provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in dietary protein intake from baseline
Time Frame: 12 weeks
|
Assessed changes in dietary protein intake from three 24-hour dietary recalls collected at baseline.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in muscle mass
Time Frame: 12 weeks
|
Changes in muscle mass from baseline were measured using bioelectrical impedance analysis
|
12 weeks
|
|
Changes in upper body muscle strength
Time Frame: 12 weeks
|
Changes in handgrip strength from baseline were measured using hand dynamometer
|
12 weeks
|
|
Changes in lower body muscle strength and function
Time Frame: 12 weeks
|
Changes in 5-chair stand times from baseline were assessed
|
12 weeks
|
|
Changes in muscle function
Time Frame: 12 weeks
|
Changes in 4 meter gait speed from baseline were assessed
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sareen S Gropper, PhD, Professor, College of Nursing, Florida Atlantic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 26, 2019
Primary Completion (Actual)
January 24, 2020
Study Completion (Actual)
January 24, 2020
Study Registration Dates
First Submitted
October 16, 2020
First Submitted That Met QC Criteria
December 7, 2020
First Posted (Actual)
December 9, 2020
Study Record Updates
Last Update Posted (Actual)
December 9, 2020
Last Update Submitted That Met QC Criteria
December 7, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1440147-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.